BBHvsIGSB
VanEck Biotech ETF against iShares 1-5 Year Investment Grade Corporate Bond ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBH | IGSB | |
|---|---|---|
| Expense ratio | 0.35% | 0.040% |
| Assets | $535M | $23.7B |
| Net flow, 1 month | +$25M | +$422M |
| Net flow, 1 year | +$39M | +$2B |
| Return, YTD | +31.5% | -3.0% |
| Return, 1 year | — | — |
| Avg daily volume | 17K | 3.4M |
| Holdings | 25 | 4791 |
| Listed | Nov 23, 1999 | Jan 5, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS